The role for osmotic agents in children with acute encephalopathies: a systematic review

Samson Gwer1, Hellen Gatakaa, Leah Mwai

  • 1Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Collaborative Research Programme, Kilifi, Kenya. sgwer@kilifi.kemri-wellcome.org

BMC Pediatrics
|April 20, 2010
PubMed

Insights

Hypertonic saline effectively reduces intracranial pressure in children with acute encephalopathy, outperforming mannitol. Oral glycerol also shows promise in improving outcomes for bacterial meningitis cases.

Area of Science:

  • Pediatric Neurology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Raised intracranial pressure (ICP) is a critical complication in acute encephalopathies, impacting cerebral perfusion and potentially leading to fatal outcomes.
  • Current guidelines for managing ICP in children often rely on adult data, highlighting a need for pediatric-specific evidence.
  • Osmotic agents are a cornerstone of ICP management, but their efficacy and safety in pediatric populations require thorough evaluation.

Purpose of the Study:

  • To review the existing evidence on the effectiveness of osmotic agents in reducing ICP in children with acute encephalopathy.
  • To assess the impact of osmotic agents on coma resolution, neurological sequelae, and mortality in pediatric patients.
  • To compare the efficacy of different osmotic agents, including hypertonic saline and glycerol, in the pediatric population.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases for studies published between January 1966 and March 2009.
  • Included studies focused on children aged 0-16 years with acute encephalopathies treated with osmotic agents.
  • Outcomes assessed included reduction in ICP, time to coma resolution, neurological sequelae, and mortality.

Main Results:

  • Hypertonic saline (HS) demonstrated superior and more sustained reduction in ICP compared to mannitol and other fluids, especially when administered via continuous infusion.
  • Bolus administration of glycerol and mannitol provided transient ICP reduction.
  • Oral glycerol was linked to reduced mortality and neurological sequelae in children with acute bacterial meningitis, while HS showed lower mortality than mannitol in non-traumatic encephalopathies.

Conclusions:

  • Hypertonic saline appears to be more effective in reducing ICP in children than other osmotic agents.
  • Oral glycerol may improve outcomes in pediatric acute bacterial meningitis.
  • Further research is needed to optimize the administration of osmotic agents for sustained ICP reduction in children.
Abstract

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...